Specialty code 183500000X · Stockton, CA
NPI
1669812590
Since 2013
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
7373 West Ln
Stockton, CA, 95210
Phone (209) 476-2000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$379K
1,780 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Emmanuel D Manaois prescribed most often to Medicare patients was Ozempic (Semaglutide), with 256 prescriptions and refills. In total Emmanuel D Manaois wrote 1,780 Medicare prescriptions that cost $379K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 256 | 275 | 43 | $189K |
| Humulin N Insulin Nph Human Isophane | 173 | 514 | 69 | $30K |
| Glipizide Generic | 147 | 479 | 60 | $2,358 |
| Metformin Hcl Er Metformin Hcl | 139 | 463 | 53 | $1,391 |
| Atorvastatin Calcium Generic | 135 | 424 | 58 | $1,517 |
| Metformin Hcl Generic | 134 | 442 | 49 | $1,618 |
| Jardiance Empagliflozin | 94 | 303 | 36 | $52K |
| Humulin R Insulin Regular, Human | 91 | 259 | 34 | $13K |
| Insulin Glargine-Yfgn Generic | 63 | 178 | 29 | $9,751 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 59 | 162 | 23 | $1,297 |
| Glipizide Er Glipizide | 47 | 150 | 19 | $1,173 |
| Lisinopril Generic | 47 | 157 | 18 | $555 |
| Losartan Potassium Generic | 38 | 127 | 15 | $534 |
| Simvastatin Generic | 37 | 123 | 13 | $421 |
| Rosuvastatin Calcium Generic | 30 | 100 | 12 | $340 |
Brand drugs: 801 claims; generic drugs: 849 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Emmanuel D Manaois were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.